Scientific Papers

Association of PSA variability with prostate cancer development using large-scale medical information data: a retrospective cohort study | Genes and Environment


  • Cancer Today. World Health Organization. 2020. https://gco.iarc.fr/today/home. Accessed 16 September 2021.

  • Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49. https://doi.org/10.3322/caac.21660.

    Article 
    PubMed 

    Google Scholar
     

  • Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108. https://doi.org/10.3322/caac.21262.

    Article 
    PubMed 

    Google Scholar
     

  • Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90. https://doi.org/10.3322/caac.20107.

    Article 
    PubMed 

    Google Scholar
     

  • Cancer Statistics Predictions. National Cancer Center Japan. 2021. http://ganjoho.jp/reg_stat/statistics/stat/short_pred.html. Accessed 16 September 2021.

  • Katanoda K, Hori M, Saito E, Shibata A, Ito Y, Minami T, et al. Updated trends in cancer in Japan: incidence in 1985–2015 and mortality in 1958–2018-A sign of decrease in cancer incidence. J Epidemiol. 2021;31:426–50. https://doi.org/10.2188/jea.JE20200416.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Stenman UH, Leinonen J, Zhang WM, Finne P. Prostate-specific antigen. Semin Cancer Biol. 1999;9:83–93. https://doi.org/10.1006/scbi.1998.0086.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Balk SP, Ko YJ, Bubley GJ. Biology of prostate-specific antigen. J Clin Oncol. 2003;21:383–91. https://doi.org/10.1200/JCO.2003.02.083.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Committee for Establishment of the Guidelines on Screening for Prostate Cancer, Japanese Urological Association. Updated japanese Urological Association Guidelines on prostate-specific antigen-based screening for prostate cancer in 2010. Int J Urol. 2010;17:830–8. https://doi.org/10.1111/j.1442-2042.2010.02613.x.

    Article 
    CAS 

    Google Scholar
     

  • Egawa S, Matsumoto K, Yoshida K, Iwamura M, Kuwao S, Koshiba K. Results of transrectal ultrasound-guided biopsies and clinical significance of japanese prostate cancer. Jpn J Clin Oncol. 1998;28:666–72. https://doi.org/10.1093/jjco/28.11.666.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Ito K, Raaijmakers R, Roobol M, Wildhagen M, Yamanaka H, Schröder FH. Prostate carcinoma detection and increased prostate-specific antigen levels after 4 years in dutch and japanese males who had no evidence of disease at initial screening. Cancer. 2005;103:242–50. https://doi.org/10.1002/cncr.20739.

    Article 
    PubMed 

    Google Scholar
     

  • Sawada K, Kitagawa Y, Ito K, Takeda Y, Mizokami A, Namiki M. Cumulative risk of developing prostate cancer in men with low ( 2.0 ng/mL) prostate-specific antigen levels: a population-based screening cohort study in Japan. Int J Urol. 2014;21:560–5. https://doi.org/10.1111/iju.12380.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • McGreevy K, Rodgers K, Lipsitz S, Bissada N, Hoel D. Impact of race and baseline PSA on longitudinal PSA. Int J Cancer. 2006;118:1773–6. https://doi.org/10.1002/ijc.21553.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Roach M, Hanks G, Thames H Jr., Schellhammer P, Shipley WU, Sokol GH, et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys. 2006;65:965–74. https://doi.org/10.1016/j.ijrobp.2006.04.029.

    Article 
    PubMed 

    Google Scholar
     

  • Fujimoto K, Hirao Y, Masumori N, Arai Y, Yamanaka H, Kato T, et al. Prostate-specific antigen changes as a result of chlormadinone acetate administration to patients with benign prostatic hyperplasia: a retrospective multi-institutional study. Int J Urol. 2006;13:543–9. https://doi.org/10.1111/j.1442-2042.2006.01343.x.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Wright FL, Green J, Canoy D, Cairns BJ, Balkwill A, Beral V. Vascular disease in women: comparison of diagnoses in hospital episode statistics and general practice records in England. BMC Med Res Methodol. 2012;12:161. https://doi.org/10.1186/1471-2288-12-161.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Thygesen SK, Christiansen CF, Christensen S, Lash TL, Sørensen HT. The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based danish National Registry of Patients. BMC Med Res Methodol. 2011;11:83. https://doi.org/10.1186/1471-2288-11-83.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Gradus JL, Qin P, Lincoln AK, Miller M, Lawler E, Sorensen HT, et al. Posttraumatic stress disorder and completed suicide. Am J Epidemiol. 2010;171:721–7. https://doi.org/10.1093/aje/kwp456.

    Article 
    PubMed 

    Google Scholar
     

  • Junqueira RMP, Duarte EC. Hospitalizations due to ambulatory care-sensitive conditions in the Federal District, Brazil, 2008. Rev Saude Publica. 2012;46:761–8. https://doi.org/10.1590/s0034-89102012000500001.

    Article 
    PubMed 

    Google Scholar
     

  • Okihara K, Kitamura K, Okada K, Mikami K, Ukimura O, Miki T. Ten year trend in prostate cancer screening with high prostate-specific antigen exposure rate in Japan. Int J Urol. 2008;15:156–60. https://doi.org/10.1111/j.1442-2042.2007.01957.x.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Finne P, Auvinen A, Määttänen L, Tammela TL, Ruutu M, Juusela H, et al. Diagnostic value of free prostate-specific antigen among men with a prostate-specific antigen level of < 3.0 µg per liter. Eur Urol. 2008;54:36270. https://doi.org/10.1016/j.eururo.2007.10.056. Epub 2007 Nov 5.

    Article 
    CAS 

    Google Scholar
     

  • Sasaki M, Ishidoya S, Ito A, Saito H, Yamada S, Mitsuzuka K, et al. Low percentage of free prostate-specific antigen (PSA) is a strong predictor of later detection of prostate cancer among japanese men with serum levels of total PSA of 4.0 ng/mL or less. Urology. 2014;84:1163–7. https://doi.org/10.1016/j.urology.2014.04.055.

    Article 
    PubMed 

    Google Scholar
     

  • Fujizuka Y, Ito K, Oki R, Suzuki R, Sekine Y, Koike H, et al. Predictive value of different prostate-specific antigen-based markers in men with baseline total prostate-specific antigen < 2.0 ng/mL. Int J Urol. 2017;24:602–9. https://doi.org/10.1111/iju.13381.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Gottlieb B, Lombroso R, Beitel LK, Trifiro MA. Molecular pathology of the androgen receptor in male (in)fertility. Reprod Biomed Online. 2005;10:42–8. https://doi.org/10.1016/s1472-6483(10)60802-4.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Shang Y, Myers M, Brown M. Formation of the androgen receptor transcription complex. Mol Cell. 2002;9:601–10. https://doi.org/10.1016/s1097-2765(02)00471-9.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Kang Z, Jänne OA, Palvimo JJ. Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor. Mol Endocrinol. 2004;18:2633–48. https://doi.org/10.1210/me.2004-0245.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Wang Q, Carroll JS, Brown M. Spatial and temporal recruitment of androgen receptor and its coactivators involves chromosomal looping and polymerase tracking. Mol Cell. 2005;19:631–42. https://doi.org/10.1016/j.molcel.2005.07.018.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Obinata D, Takayama K, Urano T, Murata T, Kumagai J, Fujimura T, et al. Oct1 regulates cell growth of LNCaP cells and is a prognostic factor for prostate cancer. Int J Cancer. 2012;130:1021–8. https://doi.org/10.1002/ijc.26043.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Dai X, Fang X, Ma Y, Xianyu J. Benign prostatic hyperplasia and the risk of prostate cancer and bladder cancer: a meta-analysis of observational studies. Med (Baltim). 2016;95:e3493. https://doi.org/10.1097/MD.0000000000003493.

    Article 
    CAS 

    Google Scholar
     

  • Kang D, Chokkalingam AP, Gridley G, Nyren O, Johansson JE, Adami HO, et al. Benign prostatic hyperplasia and subsequent risk of bladder cancer. Br J Cancer. 2007;96:1475–9. https://doi.org/10.1038/sj.bjc.6603730.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Uemura H, Oya M, Kamoto T, Sugimoto M, Shinozaki K, Morita K, et al. The prevalence of gene mutations in homologous recombination repair pathways in japanese patients with metastatic castration-resistant prostate cancer in real-world clinical practice: the multi-institutional observational ZENSHIN study. Cancer Med. 2023;12:5265–74. https://doi.org/10.1002/cam4.5333.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Hellwege JN, Stallings S, Torstenson ES, Carroll R, Borthwick KM, Brilliant MH, et al. Heritability and genome-wide association study of benign prostatic hyperplasia (BPH) in the eMERGE network. Sci Rep. 2019;9:6077. https://doi.org/10.1038/s41598-019-42427-z.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Ke ZB, Cai H, Wu YP, Lin YZ, Li XD, Huang JB, et al. Identification of key genes and pathways in benign prostatic hyperplasia. J Cell Physiol. 2019;234:19942–50. https://doi.org/10.1002/jcp.28592.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Matsushita M, Fujita K, Nonomura N. Influence of Diet and Nutrition on prostate Cancer. Int J Mol Sci. 2020;21:1447. https://doi.org/10.3390/ijms21041447.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Bostwick DG, Burke HB, Djakiew D, Euling S, Ho SM, Landolph J, et al. Timms B. Human prostate cancer risk factors. Cancer. 2004;101:2371–490. https://doi.org/10.1002/cncr.20408.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Nomura AM, Kolonel LN. Prostate cancer: a current perspective. Epidemiol Rev. 1991;13:200–27. https://doi.org/10.1093/oxfordjournals.epirev.a036069.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Jung JH, Ahn SV, Song JM, Chang SJ, Kim KJ, Kwon SW, et al. Obesity as a risk factor for Prostatic Enlargement: a retrospective cohort study in Korea. Int Neurourol J. 2016;20:321–8. https://doi.org/10.5213/inj.1632584.292.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Araki H, Watanabe H, Mishina T, Nakao M. High-risk group for benign prostatic hypertrophy. Prostate. 1983;4:253–64. https://doi.org/10.1002/pros.2990040305.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Shibata A, Whittemore AS, Imai K, Kolonel LN, Wu AH, John EM, et al. Serum levels of prostate-specific antigen among japanese-american and native japanese men. J Natl Cancer Inst. 1997;89:1716–20. https://doi.org/10.1093/jnci/89.22.1716.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Bergengren O, Pekala KR, Matsoukas K, Fainberg J, Mungovan SF, Bratt O, et al. 2022 update on prostate Cancer epidemiology and risk Factors-A systematic review. Eur Urol. 2023;84:191–206. https://doi.org/10.1016/j.eururo.2023.04.021.

    Article 
    PubMed 

    Google Scholar
     

  • Gandaglia G, Leni R, Bray F, Fleshner N, Freedland SJ, Kibel A, et al. Epidemiology and Prevention of prostate Cancer. Eur Urol Oncol. 2021;4:877–92. https://doi.org/10.1016/j.euo.2021.09.006.

    Article 
    PubMed 

    Google Scholar
     

  • Miah S, Catto J. BPH and prostate cancer risk. Indian J Urol. 2014;30:214–8. https://doi.org/10.4103/0970-1591.126909.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     



  • Source link